Meritxell Perramón

452 total citations
15 papers, 326 citations indexed

About

Meritxell Perramón is a scholar working on Hepatology, Materials Chemistry and Epidemiology. According to data from OpenAlex, Meritxell Perramón has authored 15 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Materials Chemistry and 5 papers in Epidemiology. Recurrent topics in Meritxell Perramón's work include Advanced Nanomaterials in Catalysis (7 papers), Liver physiology and pathology (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Meritxell Perramón is often cited by papers focused on Advanced Nanomaterials in Catalysis (7 papers), Liver physiology and pathology (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Meritxell Perramón collaborates with scholars based in Spain, China and United States. Meritxell Perramón's co-authors include Wladimiro Jiménez, Guillermo Fernández‐Varo, Manuel Morales‐Ruiz, Eudald Casals, Gregori Casals, Víctor Puntes, Pedro Melgar‐Lesmes, Marina Parra‐Robert, Silvia Carvajal and Denise Oró and has published in prestigious journals such as Hepatology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Meritxell Perramón

13 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meritxell Perramón Spain 10 149 69 60 58 54 15 326
Bernardino González de la Presa Spain 7 113 0.8× 63 0.9× 63 1.1× 33 0.6× 39 0.7× 17 302
Silvia Carvajal Spain 8 169 1.1× 67 1.0× 77 1.3× 58 1.0× 59 1.1× 13 347
Marina Parra‐Robert Spain 11 207 1.4× 78 1.1× 63 1.1× 74 1.3× 95 1.8× 24 458
Xiang Song China 11 95 0.6× 37 0.5× 16 0.3× 108 1.9× 84 1.6× 13 335
Jordi Ribera Spain 11 104 0.7× 160 2.3× 182 3.0× 113 1.9× 52 1.0× 16 464
Yingjian Hou China 11 126 0.8× 26 0.4× 13 0.2× 194 3.3× 56 1.0× 17 455
Vedrana Reichenbach Spain 11 95 0.6× 137 2.0× 144 2.4× 72 1.2× 39 0.7× 15 481
Vaishaali Natarajan United States 7 86 0.6× 63 0.9× 110 1.8× 138 2.4× 154 2.9× 8 421
Yujuan Shi China 9 59 0.4× 30 0.4× 16 0.3× 156 2.7× 72 1.3× 26 410
Jiawei Cao China 13 69 0.5× 177 2.6× 173 2.9× 45 0.8× 22 0.4× 18 383

Countries citing papers authored by Meritxell Perramón

Since Specialization
Citations

This map shows the geographic impact of Meritxell Perramón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meritxell Perramón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meritxell Perramón more than expected).

Fields of papers citing papers by Meritxell Perramón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meritxell Perramón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meritxell Perramón. The network helps show where Meritxell Perramón may publish in the future.

Co-authorship network of co-authors of Meritxell Perramón

This figure shows the co-authorship network connecting the top 25 collaborators of Meritxell Perramón. A scholar is included among the top collaborators of Meritxell Perramón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meritxell Perramón. Meritxell Perramón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Perramón, Meritxell, Guillermo Fernández‐Varo, Gregori Casals, et al.. (2025). Polymeric nanoparticles for liver-targeted pituitary tumor-transforming gene 1 silencing in rats with chronic liver disease. Nanomedicine Nanotechnology Biology and Medicine. 69. 102860–102860.
2.
Perramón, Meritxell, et al.. (2025). Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis. International Journal of Molecular Sciences. 26(16). 7780–7780.
3.
Perramón, Meritxell, Guillermo Fernández‐Varo, Cristina Fornaguera, et al.. (2024). Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats. Biomedicine & Pharmacotherapy. 171. 116143–116143. 3 indexed citations
4.
Fundora, Yiliam, Meritxell Perramón, Marina Parra‐Robert, et al.. (2023). RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration. Science Translational Medicine. 15(704). eabq6225–eabq6225. 25 indexed citations
5.
Perramón, Meritxell & Wladimiro Jiménez. (2022). Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases. International Journal of Molecular Sciences. 23(13). 6897–6897. 9 indexed citations
6.
Perramón, Meritxell, Silvia Carvajal, Vedrana Reichenbach, et al.. (2022). The pituitary tumour‐transforming gene 1/delta‐like homologue 1 pathway plays a key role in liver fibrogenesis. Liver International. 42(3). 651–662. 8 indexed citations
7.
Casals, Gregori, Meritxell Perramón, Eudald Casals, et al.. (2021). Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases. Antioxidants. 10(5). 660–660. 57 indexed citations
8.
Perramón, Meritxell, Marina Parra‐Robert, Gina M. Butrico, et al.. (2021). Validation of a Gas Chromatography-Mass Spectrometry Method for the Measurement of the Redox State Metabolic Ratios Lactate/Pyruvate and β-Hydroxybutyrate/Acetoacetate in Biological Samples. International Journal of Molecular Sciences. 22(9). 4752–4752. 13 indexed citations
9.
Parra‐Robert, Marina, Muling Zeng, Guillermo Fernández‐Varo, et al.. (2021). Mesoporous silica coated CeO2 nanozymes with combined lipid-lowering and antioxidant activity induce long-term improvement of the metabolic profile in obese Zucker rats. Nanoscale. 13(18). 8452–8466. 19 indexed citations
10.
Fernández‐Varo, Guillermo, Meritxell Perramón, Silvia Carvajal, et al.. (2020). Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma. Hepatology. 72(4). 1267–1282. 47 indexed citations
11.
Carvajal, Silvia, Meritxell Perramón, Denise Oró, et al.. (2019). Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Scientific Reports. 9(1). 12848–12848. 40 indexed citations
12.
Parra‐Robert, Marina, Eudald Casals, Muling Zeng, et al.. (2019). Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis. Biomolecules. 9(9). 425–425. 36 indexed citations
13.
Melgar‐Lesmes, Pedro, Meritxell Perramón, & Wladimiro Jiménez. (2019). Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis. Cells. 8(11). 1311–1311. 34 indexed citations
14.
Carvajal, Silvia, Meritxell Perramón, Gregori Casals, et al.. (2019). Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes. International Journal of Molecular Sciences. 20(23). 5959–5959. 34 indexed citations
15.
Carvajal, Silvia, Denise Oró, Guillermo Fernández‐Varo, et al.. (2017). Therapeutic effect of cerium oxide nanoparticles (CeO2NPs) in rats with diet-induced non-alcoholic steatohepatitis. Journal of Hepatology. 66(1). S608–S608. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernardino González de la Presa Breakdown of academic impact, for papers by Silvia Carvajal Breakdown of academic impact, for papers by Marina Parra‐Robert Breakdown of academic impact, for papers by Xiang Song Breakdown of academic impact, for papers by Jordi Ribera Breakdown of academic impact, for papers by Yingjian Hou Breakdown of academic impact, for papers by Vedrana Reichenbach Breakdown of academic impact, for papers by Vaishaali Natarajan Breakdown of academic impact, for papers by Yujuan Shi Breakdown of academic impact, for papers by Jiawei Cao
Rankless by CCL
2026